Samuel Amintas

723 total citations
27 papers, 441 citations indexed

About

Samuel Amintas is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Samuel Amintas has authored 27 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Samuel Amintas's work include CRISPR and Genetic Engineering (6 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Samuel Amintas is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Samuel Amintas collaborates with scholars based in France, Switzerland and Canada. Samuel Amintas's co-authors include Sandrine Dabernat, Aurélie Bedel, François Moreau‐Gaudry, Julian Boutin, Thierry Levade, Jeffrey A. Medin, V. Vendrely, Jean‐Philippe Merlio, Étienne Buscail and Louis Buscail and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Samuel Amintas

24 papers receiving 431 citations

Peers

Countries citing papers authored by Samuel Amintas

Since Specialization

Citations

This map shows the geographic impact of Samuel Amintas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Amintas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Amintas more than expected).

Fields of papers citing papers by Samuel Amintas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Amintas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Amintas. The network helps show where Samuel Amintas may publish in the future.

Co-authorship network of co-authors of Samuel Amintas

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Amintas. A scholar is included among the top collaborators of Samuel Amintas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Amintas. Samuel Amintas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha-1 antitrypsin deficiency and primary liver cancers 2025 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Carolin V. Schneider, (unknown), Aurélie Bèaufrere, Audrey Payancé, Audrey Coilly, Kai Markus Schneider, P Bioulac, Jean‐Frédéric Blanc, Brigitte Le Bail, Samuel Amintas, Marion Bouchecareilh	0
2	Preoperative Prognostic Factors in Resectable Pancreatic Cancer: State of the Art and Prospects 2025 ·Annals of Surgical Oncology ·(unknown), John M. Rossi, (unknown), Marion Marty, Samuel Amintas, Camille Laurent, Sandrine Dabernat	1
3	Recycled formalin: a new tool to mitigate the environmental impact of surgical pathology in routine practice 2025 ·Pathology ·Anne Rullier, Samuel Amintas, (unknown), Brigitte Le Bail, Geneviève Belleannée, Pierre Dubus, (unknown), N. Bernard	0
4	Resveratrol and capsaicin as safer radiosensitizers for colorectal cancer compared to 5-fluorouracil 2025 ·Biomedicine & Pharmacotherapy ·Samuel Amintas, Charles Dupin, Marie‐Alix Derieppe, Isabelle Moranvillier, (unknown), (unknown), (unknown), Benjamı́n Fernández, (unknown), François Moreau‐Gaudry, Aurélie Bedel, V. Vendrely, Sandrine Dabernat	2
5	Local Regrowth After a Watch-and-Wait Strategy for Middle and Low Rectal Cancer: Is Organ Preservation Still Feasible? 2025 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), Samuel Amintas, Denis Smith, Bertrand Célérier, V. Vendrely, Benjamı́n Fernández	0
6	Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis 2024 ·Journal of Physiology and Biochemistry ·(unknown), Samuel Amintas, Stéphanie Krisa, Arnaud Courtois, Tristan Richard, Itziar Eseberri, María P. Portillo	2
7	Integrating allele-specific PCR with CRISPR-Cas13a for sensitive KRAS mutation detection in pancreatic cancer 2024 ·Journal of Biological Engineering ·Samuel Amintas, Grégoire Cullot, (unknown), (unknown), (unknown), Béatrice Turcq, Valérie Prouzet‐Mauleon, Aurélie Bedel, François Moreau‐Gaudry, David Cappellen, Sandrine Dabernat	2
8	Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation 2024 ·Cancer Cytopathology ·(unknown), (unknown), (unknown), Marion Marty, Geneviève Belleannée, Arthur Berger, C. Subtil, Camille Laurent, Sandrine Dabernat, Samuel Amintas	2
9	Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9 2023 ·Nature Communications ·Grégoire Cullot, Julian Boutin, (unknown), (unknown), (unknown), David Cappellen, (unknown), Perrine Pennamen, Julie Bouron, Samuel Amintas, (unknown), Isabelle Moranvillier, Elodie Laharanne, Jean‐Philippe Merlio, Veronique Guyonnet‐Dupérat, Jean‐Marc Blouin, Emmanuel Richard, Sandrine Dabernat, François Moreau‐Gaudry, Aurélie Bedel	16
10	Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements 2023 ·The CRISPR Journal ·Grégoire Cullot, Samuel Amintas, (unknown), Valérie Prouzet‐Mauleon, (unknown), (unknown), David Cappellen, Aurélie Bedel, François Moreau‐Gaudry, Stéphanie Dulucq, Sandrine Dabernat, Béatrice Turcq	3
11	Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2/BCL6 Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma 2023 ·Modern Pathology ·(unknown), (unknown), (unknown), (unknown), Elodie Laharanne, Samuel Amintas, Jean‐Philippe Merlio, Krimo Bouabdallah, François‐Xavier Gros, Laurence de Leval, Audrey Gros, Marie Parrens	1
12	The Crying Need for a Better Response Assessment in Rectal Cancer 2023 ·Current Treatment Options in Oncology ·Samuel Amintas, Nicolas Giraud, Benjamı́n Fernández, Charles Dupin, Quentin Denost, Aurélie Garant, Nora Frulio, Denis Smith, Anne Rullier, Éric Rullier, T. Vuong, Sandrine Dabernat, V. Vendrely	7
13	ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected 2022 ·The CRISPR Journal ·Julian Boutin, David Cappellen, (unknown), Samuel Amintas, Sandrine Dabernat, Aurélie Bedel, François Moreau‐Gaudry	29
14	Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer 2022 ·European Journal of Cancer ·(unknown), Samuel Amintas, Charline Caumont, Rémi Veillon, (unknown), (unknown), (unknown), Charlotte Domblides, Amandine Gouverneur, Jean‐Philippe Merlio, Julien Bezin, Pierre‐Olivier Girodet	24
15	KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence 2022 ·Scientific Reports ·Samuel Amintas, Benjamı́n Fernández, (unknown), L. Chiche, Camille Laurent, Geneviève Belleannée, Marion Marty, Étienne Buscail, Sandrine Dabernat	8
16	A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma 2022 ·Acta Dermato Venereologica ·(unknown), (unknown), (unknown), M. Beylot‐Barry, Julien Sénéschal, B. Milpied, Jean-Philippe Vial, Audrey Gros, Samuel Amintas, B. Vergier, Anne Pham‐Ledard	2
17	Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA 2021 ·Frontiers in Cell and Developmental Biology ·Samuel Amintas, V. Vendrely, Charles Dupin, Louis Buscail, Camille Laurent, Barbara Bournet, Jean‐Philippe Merlio, Aurélie Bedel, François Moreau‐Gaudry, Julian Boutin, Sandrine Dabernat, Étienne Buscail	31
18	Spleen route accelerates engraftment of human hematopoietic stem cells 2021 ·Biochemical and Biophysical Research Communications ·Aurélie Bedel, Julian Boutin, Samuel Amintas, Isabelle Lamrissi‐Garcia, Benoı̂t Rousseau, Sandrine Poglio, Philippe Brunet de la Grange, Isabelle Moranvillier, Jean‐Marc Blouin, Emmanuel Richard, François Moreau‐Gaudry, Sandrine Dabernat	1
19	Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells 2020 ·Stem Cell Reports ·(unknown), Jérôme Toutain, Julian Boutin, Samuel Amintas, Grégoire Cullot, Magalie Lalanne, Isabelle Lamrissi‐Garcia, Isabelle Moranvillier, Emmanuel Richard, Jean‐Marc Blouin, Sandrine Dabernat, François Moreau‐Gaudry, Aurélie Bedel	4
20	Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death 2019 ·Cancer Letters ·V. Vendrely, Samuel Amintas, (unknown), Isabelle Moranvillier, (unknown), Benoı̂t Rousseau, (unknown), Aurélie Bedel, François Moreau‐Gaudry, Étienne Buscail, L. Chiche, Geneviève Belleannée, Charles Dupin, Sandrine Dabernat	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact